California Awards $12 Million to Stanford Scientist for a Clinical Trial to Test a T-Cell Therapy for Extremely Rare Disease
IPEX syndrome is the target, the research might have implications for more common afflictions
The California stem cell agency yesterday awarded $12 million to a Stanford researcher to begin a clinical trial involving an extremely rare affliction affecting only an estimated 330 persons in the United States.
The disease is an immune disorder known as IPEX syndrome and is often fatal. The award wou…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.